Low risk of disease recurrence, defined by the following criteria: - Absence of lymph node involvement (ypN0), assessed on a min. of 15 lymph nodes and, - Either ypT0-2 ( all TRG grade) or ypT3 (with TRG 1a-b according to Becker classification or TRG1-2 according to Mandard’s classification),

• ATTENUATION – A multicenter randomized phase II study of the efficacy and safety de-escalation versus standard adjuvant chemotherapy in pati … Ended
  2023-509227-41-00 4

Showing 1–1 of 1 trials